Release date: October 1, 2009
Expiration date: September 30, 2010
Estimated time to complete this activity: 2 hours

Target Learners:
This activity is intended for rheumatologists.

Learning Objectives
After completing this activity, participants should be able to:
• Interpret the impact of clinical decision making of new safety and efficacy data on emerging biologic therapies.
• Integrate early, aggressive treatment to prevent disease progression and joint damage.
• Integrate endpoints such as American College of Rheumatology (ACR) scores, Disease Activity Score (DAS), and radiographic
remission into ongoing assessment of patients with RA.
• Assess and manage cardiovascular disease risk in patients with RA.

Faculty
Leonard H. Calabrese, DO, Chair
Cleveland Clinic Lerner College of Medicine
Cleveland, OH

Ernest Choy, MD
Weston Education Center
London, UK

Jonathan Kay, MD
University of Massachusetts
Medical School
Worcester, MA

Paul Emery, MD
Leeds Institute of Molecular Medicine
University of Leeds
Leeds, UK

Accreditation Statement
This activity was planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Interstate Postgraduate Medical Association and MEV Healthcom, Inc. Interstate Postgraduate Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Interstate Postgraduate Medical Association designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.

Commercial Support
Interstate Postgraduate Medical Association and MEV Healthcom, Inc., gratefully acknowledge Roche for providing an educational grant in support of this activity.

Method of Participation
Physician learners will participate in this educational activity by reading this education content, completing the post-test and evaluation. Learners must complete a post-test and evaluation and receive a passing score of 70% or more on the post-test. This activity should take 2 hours to complete.

Faculty and Planners Disclosure Statement
As a provider dedicated to independent education and accredited by the ACCME, Interstate Postgraduate Medical Association (IPMA) must ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. It is the policy of IPMA to require disclosure of the existence of any significant financial interest or other relationship a faculty member, planner, or a sponsor has with either the commercial supporter of this activity or the manufacturer(s) of any commercial product(s) discussed in an educational presentation.

Faculty Disclosures
Leonard H. Calabrese, DO — Advisory Board: Genentech, Amgen, Wyeth, Roche, Centocor, UCB, Abbott. Speaker's Bureau: Genentech, Amgen, Wyeth, Roche, Centocor, UCB, Abbott. Consultant: Genentech, Wyeth, Roche.
Ernest Choy, MD — Advisory Board: Roche, UCB Celltech, Wyeth, GSK Genetech, Pfizer. Speaker's Bureau: Roche, UCB Celltech. Consultant: Roche, Schering-Plough, UCB Celltech.
Paul Emery, MD — Advisory Board: Amgen, Centocor, Genentech, GlaxoSmithKline/Human Genome Sciences, Roche, Sanofi-Aventis, UCB, Wyeth. Research: Amgen, Centocor, Genentech, Novartis. Consultant: Abbott, Amgen, Array BioPharma, Centocor, Genentech, GlaxoSmithKline/Human Genome Sciences, Roche, Sanofi-Aventis, UCB, Wyeth.
Jonathan Kay, MD — Advisory Board: Amgen, Roche, Wyeth, Genentech, Centocor. Research: Amgen, Genentech, Pfizer, Centocor. Consultant: Centocor.

Planner Disclosures
Mary W. Ales, Investment-Amgen.
No other planners or staff who could influence the content of this activity have any relations with relevant commercial interests to disclose.

Writer
Alex Castellino, PhD, Nothing to disclose.

Disclosure of Unapproved Use
This activity discusses tocilizumab. At the time of publication, this drug has not been approved for use by the Food and Drug Administration (FDA).

Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that the faculty are expressing the views of the Interstate Postgraduate Medical Association, MEV Healthcom, Inc., or any other company.

Peer Review
This activity has been reviewed by a physician of the target audience.

Privacy Policy
At Interstate Postgraduate Medical Association (IPMA) we care about providing you with tools and information to manage and protect your online privacy.  IPMA retains records solely for keeping records in accordance with ACCME policies.  We will not share your information with any other organizations.  We will keep you informed of our CME activities.
 
Please email cmehelp@ipmameded.org  if you do not want to receive any communications from us.
 
Copyright
All material on this website is protects by copyright.  Copyright 2009 by IPMA.  This also contains material copyrighted by 3rd parties.
 
Contact Information
IPMA
PO Box 5474
Madison, WI  53705
608.231.9045  fax 877.292.4489
cmehelp@ipmameded.org

Review Activity       Online Post Test